Work

Mouse Embryonic Hematopoietic Lineage Differentiation In Vitro

Year: 2014
Type: dissertation
Abstract: Hematopoietic differentiation from embryonic stem cells (ESC) is the result of a complex and regulated process, dependent on a transcriptionally controlled network of signaling outcomes. Although several aspects of this differentiation process have been elucidated, critical components such as the identification of a hematopoietic-restricted progenitor have not been well characterized. In this study, ESCs lacking the transcriptional regulator Ldb1 (Lim-domain-binding-1), required for the formation of a protein complex with Lmo2 (Lim-domain-only-2), Scl (stem-cell-leukemia-protein), and GATA2 (GATA-binding-protein-2), were utilized. The loss of Ldb1 prevents the formation of this complex, resulting in the ablation of Runx1 (runt-related transcription factor1) expression, leading to a loss of hematopoiesis. This block in hematopoiesis allowed for the identification of a pre-hematopoietic lineage (pHL) progenitor that lacks CD41 (integrin2α) and CD45 (leukocyte-common-antigen) expression, but displays CD105 (endoglin), CD117 (stem-cell-factor-receptor), CD202b (angiopoietin-receptor-2) expression. Through genetic, phenotypic, and functional characterizations of pHL progenitors' hematopoietic and endothelial differentiation potentials, it was observed that the loss of Ldb1 does not interfere with endothelial lineage differentiation; while Ldb1-sufficient pHL progenitors have the potential to give rise to CD45+ hematopoietic cells with lymphoid potential in vitro, and thus fulfill a key aspect of definitive hematopoietic development. The secondary objective of this thesis is the characterization of hematopoietic development when HoxB4 (homeobox-protein-B4) protein is introduced to developing ESCs in vitro, by co-culture with OP9 stromal cells ectopically expressing a secreted, soluble form of HoxB4 (HoxB4-OP9). Previous findings showed that ectopically expressing HoxB4 in ESC-derived hematopoietic progenitors could achieve long-term hematopoietic reconstitution in immune compromised mice with unknown mechanism. However, the use of retroviral vectors poses major obstacles for clinical applications. By characterizing pHL and CD201+ pHL (pHL expressing CD201, activated-endothelial-protein-C-receptor) progenitors derived from HoxB4-OP9/ESC co-cultures, it was observed that subsequent hematopoietic development were comparable to the retrovirally-induced ectopic HoxB4 expression model; while endothelial/hematopoietic bi-potent progenitors developed from HoxB4-OP9 co-cultures did not have significantly perturbed endothelial developmental potential.Together, the findings presented in this thesis support the use of pre-hematopoietic progenitors derived from embryonic stem cells as a viable approach to further characterize the potential to generate hematopoietic cells with in vivo reconstitution ability.
Author: Chen Liang
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: green
OpenAlex ID: W2624953578
Cites: 85
Cited by:
Related to: 10